Skip to main content
letter
. 2021 Aug 31;12(5):324–326. doi: 10.14740/cr1315

Figure 1.

Figure 1

Acute and chronic effects of preventing heart failure by sodium-glucose cotransporter 2 inhibitors (SGLT2i). The change of estimated glomerular filtration rate (eGFR) was made by modification of our previous study [6].